错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Developing national cancer survivorship standards to inform quality of care in the United States using a consensus approach

  • Michelle A. Mollica,
  • Gina McWhirter,
  • Emily Tonorezos,
  • Joshua Fenderson,
  • David R. Freyer,
  • Michael Jefford,
  • Christopher J. Luevano,
  • Timothy Mullett,
  • Shelley Fuld Nasso,
  • Ethan Schilling,
  • Vida Almario Passero,
  • Catherine Alfano,
  • Precilla Belin,
  • Anne Blaes,
  • Hillary Cavanagh,
  • Lanie Francis,
  • David R. Freyer,
  • Danielle Friedman,
  • Shelley Fuld Nasso,
  • Patricia Ganz,
  • Min He,
  • Batsheva Honig,
  • Shawna Hudson,
  • Linda Jacobs,
  • Michael Jefford,
  • Nancy Keating,
  • Anne Kirchoff,
  • Michelle Kirschner,
  • Ron Kline,
  • Jessica MacIntyre,
  • Molly Maher,
  • Deborah Mayer,
  • Janette Merrill,
  • Timothy Mullett,
  • Larissa Nekhlyudov,
  • Frank Penedo,
  • Mackenzi Pergolotti,
  • Michael Roth,
  • Tara Sanft,
  • Alyssa Schatz,
  • Ethan Schilling,
  • Kathryn Schmitz,
  • Lisa Schwartz,
  • Emily Tonorezos

摘要

Purpose

To develop United States (US) standards for survivorship care that informs (1) essential health system policy and process components and (2) evaluation of the quality of survivorship care.

Methods

The National Cancer Institute and the Department of Veterans Affairs led a review to identify indicators of quality cancer survivorship care in the domains of health system policy, process, and evaluation/assessment. A series of three virtual consensus meetings with survivorship care and research experts and advocates was conducted to rate the importance of the indicators and refine the top indicators. The final set of standards was developed, including ten indicators in each domain.

Results

Prioritized items were survivor-focused, including processes to both assess and manage physical, psychological, and social issues, and evaluation of patient outcomes and experiences. Specific indicators focused on developing a business model for sustaining survivorship care and collecting relevant business metrics (e.g., healthcare utilization, downstream revenue) to show value of survivorship care to health systems.

Conclusions

The National Standards for Cancer Survivorship Care can be used by health systems to guide development of new survivorship care programs or services or to assess alignment and enhance services in existing survivorship programs. Given the variety of settings providing care to survivors, it is necessary for health systems to adapt these standards based on factors including age-specific needs, cancer types, treatments received, and health system resources.

Implications for Cancer Survivors

With over 18 million cancer survivors in the United States, many of whom experience varied symptoms and unmet needs, it is essential for health systems to have a comprehensive strategy to provide ongoing care. The US National Standards for Survivorship Care should serve as a blueprint for what survivors and their families can anticipate after a cancer diagnosis to address their needs.